EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Preconception Mycoplasma genitalium Seropositivity and Risk of Impaired Fecundity

Yajnaseni Chakraborti iD, Stefanie N Hinkle iD, Jørgen Skov Jensen iD, John F Alderete iD, Catherine L Haggerty iD, Toni Darville iD, Sunni L Mumford iD, Enrique F Schisterman iD, Robert M Silver iD, Anna Overgaard Kildemoes iD, Brandie DePaoli Taylor iD

The Journal of Infectious Diseases · 13.11.2026

DOI: 10.1093/infdis/jiag554 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Infectious Diseases, online erschienen am 13.11.2026. Verfasst von Yajnaseni Chakraborti und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biostatistics, Epidemiology and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Mycoplasma genitalium (MG) is an emerging sexually transmitted infection (STI) associated with pelvic inflammatory disease. Its relationship with impaired fecundity remains unclear and is rarely examined in the context of co-seropositivity with other STIs.

Methods

We conducted a secondary analysis of the Effects of Aspirin in Gestation and Reproduction (EAGeR) trial, a prospective preconception cohort of women with proven fecundity and prior pregnancy loss. MG serostatus was determined using Western blot–based IgG assays on 1146 stored serum specimens. Chlamydia trachomatis (CT) and other STIs were also measured. Associations between MG seropositivity and measures of impaired fecundity were assessed. Pregnancy loss and live birth were modeled using inverse-probability weighted quasi-Poisson and unweighted log-binomial models to calculate relative risks (RR). Fecundability-odds-ratio (FOR) was estimated using a discrete Cox proportional hazards model accounting for left truncation and right censoring. Propensity score (PS) weighted versions of these models assessed risks associated with CT co-seropositivity. Analyses were adjusted for demographic and reproductive history variables.

Results

Overall, 17.1% (n=210) of participants were MG seropositive, with 27.6% (n=58) co-seropositive with CT. Compared to STI-seronegative women, MG seropositivity was not associated with any outcome, although trends were observed for reduced fecundability (FORadj: 0.87, 95% CI 0.70-1.08) and live birth (RRadj: 0.94, 95% CI 0.79-1.11). Co-seropositivity with CT was associated with lower likelihood of live birth [RRPS-weighted: 0.82, 95% CI: 0.70-0.96]. Sensitivity analyses supported the robustness of these findings.

Conclusions

Being co-seropositive for MG and CT preconception was associated with impaired fecundity.

Schlagwörter

Stichwörter der Autor:innen

FecundityMycoplasma genitaliumpregnancy

Autor:innen und Institutionen

  • Department of Biostatistics, Epidemiology and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  • Department of Obstetrics and Gynecology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  • Research Unit for Reproductive Microbiology, Statens Serum Institut, Copenhagen, Denmark.
  • School of Molecular Biosciences, Washington State University, Pullman, WA 99164, USA.
  • Department of Epidemiology, School of Public Health, University of Pittsburgh, Pittsburgh, PA, USA.
  • Department of Pediatrics, University of North Carolina Chapel Hill, Chapel Hill, NC, USA.

ORCID-Profile: Yajnaseni Chakraborti, Stefanie N Hinkle, Jørgen Skov Jensen, John F Alderete, Catherine L Haggerty, Toni Darville, Sunni L Mumford, Enrique F Schisterman, Robert M Silver, Anna Overgaard Kildemoes, Brandie DePaoli Taylor

Zitieren

APA

Chakraborti, Y., Hinkle, S. N., Jensen, J. S., Alderete, J. F., Haggerty, C. L., Darville, T., Mumford, S. L., Schisterman, E. F., Silver, R. M., Kildemoes, A. O., & Taylor, B. D. (2026). Preconception Mycoplasma genitalium Seropositivity and Risk of Impaired Fecundity. The Journal of Infectious Diseases. https://doi.org/10.1093/infdis/jiag554

Vancouver

Chakraborti Y, Hinkle SN, Jensen JS, Alderete JF, Haggerty CL, Darville T, et al. Preconception Mycoplasma genitalium Seropositivity and Risk of Impaired Fecundity. The Journal of Infectious Diseases. 2026. doi:10.1093/infdis/jiag554

BibTeX
@article{Chakraborti2026,
  author = {Chakraborti, Yajnaseni and Hinkle, Stefanie N and Jensen, Jørgen Skov and Alderete, John F and Haggerty, Catherine L and Darville, Toni and Mumford, Sunni L and Schisterman, Enrique F and Silver, Robert M and Kildemoes, Anna Overgaard and Taylor, Brandie DePaoli},
  title = {Preconception Mycoplasma genitalium Seropositivity and Risk of Impaired Fecundity},
  journal = {The Journal of Infectious Diseases},
  year = {2026},
  doi = {10.1093/infdis/jiag554}
}
Kostenlos starten →